In a B16-F10 mouse melanoma transplantable tumor model, a fraction of antigen-specific tumor-infiltrating CD8 T cells acquired CD69 and CD103 expression 3 weeks after tumor engraftment (149). This evidence concerns the gene CD8A and neoplasm.